← All trials
NCT00342849
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 15, 1994
- Primary completion
- Aug 29, 2007
- Completion date
- Jun 10, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 1332
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- National Institute of Environmental Health Sciences (NIEHS)Lead sponsor
- National Institute of Environmental Health Sciences (NIEHS)Overall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.